Lawrence Kenyon

CFO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

OTLK

Current role

CFO, Board Member, CEO

2 calls Latest call 2024-08-14

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Outlook Therapeutics, Inc. (OTLK)	CEO	$475,000	—	—	—	—	$1,170	$476,170
2024	Outlook Therapeutics, Inc. (OTLK)	CEO	$475,000	—	—	$158,427	—	$1,170	$634,597
2021	Outlook Therapeutics, Inc. (OTLK)	CFO	$425,000	$212,500	—	$2,008,035	—	$23,679	$2,669,214
2020	Outlook Therapeutics, Inc. (OTLK)	CFO	$425,000	$116,875	—	$621,449	—	$21,010	$1,184,334
2019	Outlook Therapeutics, Inc. (OTLK)	CEO	$425,000	—	—	$1,419,880	—	$19,021	$1,863,901
2018	Outlook Therapeutics, Inc. (OTLK)	CEO	$371,635	—	—	$326,192	—	$18,305	$716,132

Earnings-call appearances and filed executive appointments or departures, newest first.